Hydrochloric Acid

Hydrochloric Acid

SCHEMBL8914539

COc1ccccn1.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29077445 1.00
Hydrochloric Acid SCHEMBL7736230 1.00 KDM4E (0.48)
Hydrochloric Acid SCHEMBL10488703 0.98 KDM4E (0.46)
SCHEMBL29531218 0.97
SCHEMBL15561907 0.97 KDM4E (0.50)
SCHEMBL65664 0.97
Bromide SCHEMBL34472696 0.95 KDM4E (0.48)
SCHEMBL30065146 0.95
Hydrochloric Acid SCHEMBL10488706 0.95 KDM4E (0.48)
SCHEMBL28091796 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111094272-B Pharmaceutically acceptable salt and crystal form of OTR inhibitor and preparation method 江苏恒瑞医药股份有限公司 2022-05-27 CN claimed
US-5629134-A SOLVENT, ALKALI SOLUBLE RESIN, ACID GENERATOR, PYRIDINE SALT SHIN-ETSU CHEMICAL CO., LTD. (JP) 1997-05-13 US claimed
CN-220611264-U Omeprazole chloride processing device 济宁华能制药厂有限公司 2024-03-19 CN disclosed
CN-111965280-B Method for rapidly determining sugar mixing ratio of Dangshan pear syrup 安徽农业大学 2023-07-25 CN disclosed
CN-116326412-A Method for regulating and controlling rhizosphere activating effect of apples 北京农学院 2023-06-27 CN disclosed
CN-110627812-B Heterocyclic compounds as TRK inhibitors 北京诺诚健华医药科技有限公司 2022-10-11 CN disclosed
EP-3983074-A1 PYRIDINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS Janssen Pharmaceutica NV (BE) 2022-04-20 EP disclosed
CN-105121437-B Coumarin derivative and method for treating cystic fibrosis, chronic obstructive pulmonary disease and misfolded protein matter illness 发现生物医药公司 2018-12-04 CN disclosed
CN-108251466-A A kind of method of enzymatic clarification esomeprazole 浙江京新药业股份有限公司 2018-07-06 CN disclosed
CN-105246887-B Coumarin derivative and the method for treating hyperproliferative disease 发现生物医药公司 2018-05-11 CN disclosed
CN-107434802-A A kind of preparation method of Esomeprazole sodium 湖北朗昕生化药业有限公司 2017-12-05 CN disclosed
CN-107400118-A The preparation method of esomeprazole intermediate 信泰制药(苏州)有限公司 2017-11-28 CN disclosed
CN-105418589-B A kind of esomeprazole magnesium trihydrate preparation method for treating disease of digestive system 青岛市中心医院 2017-09-26 CN disclosed
CN-103896916-B A kind of preparation method of Esomeprazole sodium 鲁南贝特制药有限公司 2016-08-17 CN disclosed
CN-103694223-B A kind of one kettle way prepares the method for esomeprazole magnesium 乐普药业股份有限公司 2016-08-10 CN disclosed
CN-104797572-A Pyridone derivatives as acid secretion inhibitors and process for preparing the same KARUS THERAPEUTICS LTD 2015-07-22 CN disclosed
CN-100436445-C Pyrazole derivative DAIICHI SEIYAKU CO (JP) 2008-11-26 CN disclosed
CN-1902191-A Amidopyrazole derivative DAIICHI SEIYAKU CO (JP) 2007-01-24 CN disclosed
CN-1759110-A Pyrazole derivatives DAIICHI SEIYAKU CO (JP) 2006-04-12 CN disclosed
US-5629134-A SOLVENT, ALKALI SOLUBLE RESIN, ACID GENERATOR, PYRIDINE SALT SHIN-ETSU CHEMICAL CO., LTD. (JP) 1997-05-13 US disclosed